Physician profile

Anthony Freundel

Pulmonary Disease · Williamsville, NY

NPI 1881658672

$19,902.00

in general payments reported to CMS, 2019-2025

56 companies · $4,385 in 2025

The $4,385 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$11,111.00
Education$238.84

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $3,315.04 2019-2025 Fasenra, Airsupra, Breztri
Glaxosmithkline, LLC. $2,590.01 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Boehringer Ingelheim Pharmaceuticals, INC. $1,869.67 2019-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Actelion Pharmaceuticals US, INC. $1,785.11 2019-2025 Uptravi, Opsumit
Genzyme Corporation $1,248.49 2019-2025
Grifols USA, LLC $661.85 2019-2025 Prolastin-C Liquid
Regeneron Healthcare Solutions, INC. $642.05 2019-2025 Dupixent
Insmed, INC. $616.44 2019-2025 Arikayce, Brinsupri
Mylan Specialty L.P. $581.18 2019-2024 Yupelri
Electromed, INC. $535.79 2019-2025 Smartvest
Inspire Medical Systems, INC. $515.06 2024-2025 Inspire
Pfizer INC. $475.71 2021-2025
Mallinckrodt Hospital Products INC. $471.10 2020-2025 Acthar
Amgen INC. $446.26 2021-2025 Tezspire, Tavneos, Otezla
Merck Sharp & Dohme LLC $404.20 2019-2025 Winrevair, Zerbaxa, Dificid
Show all 56 companies
CompanyGeneral paymentsYearsTop products
Bayer Healthcare Pharmaceuticals INC. $313.34 2019-2023
Verona Pharma, INC. $313.29 2025 Ohtuvayre
Philips North America LLC $231.86 2019-2025 (Ak6) Vest Therapy, Vest Therapy Und
Takeda Pharmaceuticals U.S.A., INC. $212.65 2020-2025 Glassia
United Therapeutics Corporation $196.06 2020-2023 Tyvaso
Teva Pharmaceuticals USA, INC. $184.71 2019-2022
Jazz Pharmaceuticals INC. $178.42 2019-2022
Genentech USA, INC. $171.26 2019
Inogen, INC. $170.55 2022-2024 Inogen One G5 Oxygen Concentrator - Bluetooth
Pulmonx Corporation $159.06 2023-2025 Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve
Gilead Sciences, INC. $147.28 2019-2021
Mallinckrodt Enterprises LLC $133.39 2019
Biotronik INC. $129.89 2023 Edora 8 Dr-T, Biomonitor, Acticor 7 Vr-T Dx
Viatris Specialty LLC $95.33 2025 Yupelri
La Jolla Pharmaceutical Company $93.56 2019
Axsome Therapeutics, INC. $84.81 2023-2024 Sunosi
Portola Pharmaceuticals, LLC $83.59 2019-2020
Advanced Respiratory, INC $75.00 2019-2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $70.89 2022-2024 Xifaxan
3b Medical, INC. $67.49 2024-2025 Luna
Abbvie INC. $59.60 2020-2023
Lilly USA, LLC $49.38 2023-2024 Jardiance, Zepbound, Emgality
Alexion Pharmaceuticals, INC. $44.60 2021-2022
Shire North American Group INC $44.13 2019
Fisher & Paykel Healthcare INC $43.37 2022
Paratek Pharmaceuticals, INC. $36.26 2019-2022
Kowa Pharmaceuticals America, INC. $35.66 2022
Ani Pharmaceuticals, INC. $34.12 2023-2024 Purified Cortrophin Gel
Resmed Corp $31.19 2023
Circassia INC. $30.13 2019
Sanofi-Aventis U.S. LLC $29.00 2021
Sunovion Pharmaceuticals INC. $28.57 2019
Janssen Pharmaceuticals, INC $24.46 2020
Vanda Pharmaceuticals INC. $24.37 2021
Almatica Pharma LLC $23.52 2022
Boston Scientific Corporation $17.15 2019
Novo Nordisk INC $16.57 2023 Wegovy
Currax Pharmaceuticals LLC $16.14 2022
Exact Sciences Corporation $15.26 2023 Cologuard Collection Kit
Baxter Healthcare $14.85 2023 Hillrom - Life 2000 Ventilation System
Amarin Pharma, INC. $13.28 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Anthony Freundel

$19,902.00

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $4,385 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/175961/anthony-freundel

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.